ON Biotech and Research Public Limited is set to issue an initial public offering (IPO) for general investors. The company plans to publicly issue 30 lakh ordinary shares at a par value of NPR 100 per share and has appointed Global IME Capital Limited as the issue and sales manager for the IPO.
On Magh 14 (B.S.), a formal agreement was signed between the company and the manager at a special event held at Global IME Capital, Naxal. The agreement was signed by Chairman Chunna Prasad Sharma of ON Biotech and CEO Mandip Luitel of Global IME Capital.
Registered at the Company Registrar Office on Poush 2, 2076 B.S., ON Biotech operates from its central office in Tilottama 16, Rupandehi. The company produces fresh mushrooms using agricultural waste products such as straw, husk, sugarcane bagasse, and mustard stalks. It also produces and distributes mushroom seeds using wheat, barley, and millet, covering all types of mushrooms.
In addition to fresh mushrooms, the company plans to operate dry mushroom and canned mushroom plants. It also engages in the production and marketing of seasonal vegetables, provides compost fertilizers for farmers, and is progressing with plans for organic fertilizer production and distribution. For oyster mushroom cultivation, the company prepares the required compost, and for button mushrooms, it supplies the necessary manure to farmers and commercial growers across Nepal.
ON Biotech also provides seeds, auxiliary materials, and production guidance to farmers cultivating new varieties of mushrooms commercially. The company’s team includes agricultural experts, entrepreneurs, mushroom specialists, young innovators, chartered accountants, and other professionals from reputable fields.
This article was originally published on https://bajarkochirfar.com. Translated with the help of AI and reviewed by our editorial team.
